Neutrophil to lymphocyte ratio as noninvasive predictor of pulmonary vascular resistance increase in congestive heart failure patients: Single-center preliminary report.


Journal

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ISSN: 1899-5276
Titre abrégé: Adv Clin Exp Med
Pays: Poland
ID NLM: 101138582

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 26 1 2021
Statut: ppublish

Résumé

Nowadays, heart failure (HF) is a significant health problem due to steady increase in diagnosis, unpredictable acute decompensations and high mortality rate. Early risk stratifications of clinical deterioration are essential in preventing life-threatening events and ensuring proper patients management. Increased neutrophil to lymphocytes ratio (NTLR) above 6 is associated with the risk of re-hospitalizations and increased mortality. To compare NTLR and clinical, laboratory and hemodynamic results obtained from patients re-hospitalized within six-month intervals due to HF decompensation. We evaluated 41 patients (n = 36 males (87%) and n = 5 females (13%), mean age 50 ±10 years) admitted to our hospital at least twice within six-month interval due to decompensation of chronic heart failure (CHF) between 2017 and 2019. All patients were divided into 2 groups depending on the NTLR values. There was no death in presented group during the observational time. We observed a significant difference in cardiac index (CI) - 2.4 ±0.5 compared to 2.6 ±0.6 L/m2/min - between the 1st and 2nd admission (p = 0.0356). The right ventricle systolic pressure (RVSP) results related to NTLR level revealed significant difference (43 ±14 mm Hg compared to 59 ±21 mm Hg, p = 0.0438). We observed a significant increase of pulmonary vascular resistance (PVR) values (175 ±106 compared to 438 ±300 dyn*s*cm-5, p = 0.0386) in patients with NTLR above 6. Neutrophil to lymphocyte ratio may be an easy and suitable tool for monitoring of the HF progression. According to our study, the ratio correlates with PVR and RVSP increase.

Sections du résumé

BACKGROUND
Nowadays, heart failure (HF) is a significant health problem due to steady increase in diagnosis, unpredictable acute decompensations and high mortality rate. Early risk stratifications of clinical deterioration are essential in preventing life-threatening events and ensuring proper patients management. Increased neutrophil to lymphocytes ratio (NTLR) above 6 is associated with the risk of re-hospitalizations and increased mortality.
OBJECTIVES
To compare NTLR and clinical, laboratory and hemodynamic results obtained from patients re-hospitalized within six-month intervals due to HF decompensation.
MATERIAL AND METHODS
We evaluated 41 patients (n = 36 males (87%) and n = 5 females (13%), mean age 50 ±10 years) admitted to our hospital at least twice within six-month interval due to decompensation of chronic heart failure (CHF) between 2017 and 2019. All patients were divided into 2 groups depending on the NTLR values.
RESULTS
There was no death in presented group during the observational time. We observed a significant difference in cardiac index (CI) - 2.4 ±0.5 compared to 2.6 ±0.6 L/m2/min - between the 1st and 2nd admission (p = 0.0356). The right ventricle systolic pressure (RVSP) results related to NTLR level revealed significant difference (43 ±14 mm Hg compared to 59 ±21 mm Hg, p = 0.0438). We observed a significant increase of pulmonary vascular resistance (PVR) values (175 ±106 compared to 438 ±300 dyn*s*cm-5, p = 0.0386) in patients with NTLR above 6.
CONCLUSIONS
Neutrophil to lymphocyte ratio may be an easy and suitable tool for monitoring of the HF progression. According to our study, the ratio correlates with PVR and RVSP increase.

Identifiants

pubmed: 33269817
doi: 10.17219/acem/126292
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1313-1317

Auteurs

Tomasz Kamil Urbanowicz (TK)

Cardiac Surgery and Transplantology Department, University Hospital of Lord's Transfiguration, Poznan University of Medical Sciences, Poland.

Anna Olasińska-Wiśniewska (A)

Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poland.

Michał Michalak (M)

Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poland.

Ewa Straburzyńska-Migaj (E)

Department of Cardiology, Poznan University of Medical Sciences, Poland.

Marek Jemielity (M)

Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH